My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy

• Published in: Diabetes & metabolism journal 2017, 41(1), 159, pp.1-9
• Main Authors: Brahma, Manoja K, Pepin, Mark E, Wende, Adam R
• Format: Article
• Language: English
• Subjects: Cardiomyopathies; Diabetes; Glucose; Metabolism; Review; 내과학
• ISSN: 2233-6079; 2233-6087
• DOI: 10.4093/dmj.2017.41.1.1

Despite overall reductions in heart disease prevalence, the risk of developing heart failure has remained 2-fold greater among people with diabetes. Growing evidence has supported that fluctuations in glucose level and uptake contribute to cardiovascular disease (CVD) by modifying proteins, DNA, and gene expression. In the case of glucose, clinical studies have shown that increased dietary sugars for healthy individuals or poor glycemic control in diabetic patients further increased CVD risk. Furthermore, even after decades of maintaining tight glycemic control, susceptibility to disease progression can persist following a period of poor glycemic control through a process termed "glycemic memory." In response to chronically elevated glucose levels, a number of studies have identified molecular targets of the glucose-mediated protein posttranslational modification by the addition of an O-linked N-acetylglucosamine to impair contractility, calcium sensitivity, and mitochondrial protein function. Additionally, elevated glucose contributes to dysfunction in coupling glycolysis to glucose oxidation, pentose phosphate pathway, and polyol pathway. Therefore, in the "sweetened" environment associated with hyperglycemia, there are a number of pathways contributing to increased susceptibly to "breaking" the heart of diabetics. In this review we will discuss the unique contribution of glucose to heart disease and recent advances in defining mechanisms of action.